Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103. [electronic resource]
Producer: 20110803Description: 618-28 p. digitalISSN:- 1477-2566
- Antigens, Neoplasm -- genetics
- Antineoplastic Combined Chemotherapy Protocols
- Azacitidine -- therapeutic use
- Benzamides -- therapeutic use
- Cell Line, Tumor
- DNA Methylation -- drug effects
- Epigenesis, Genetic -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Histone Deacetylase Inhibitors -- therapeutic use
- Humans
- Male
- Multiple Myeloma -- genetics
- Neoplasm Proteins -- genetics
- Pyrimidines -- therapeutic use
- Secondary Prevention
- T-Lymphocytes, Cytotoxic -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.